Nevro Corp reports results for the quarter ended December 31 - Earnings Summary

• Nevro Corp NVRO.N reported a quarterly adjusted loss of 40 cents​​ per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -25 cents. The mean expectation of fourteen analysts for the quarter was for a loss of 77 cents per share. Wall Street expected results to range from -95 cents to -65 cents per share.

• Revenue fell 9.1% to $105.55 million from a year ago; analysts expected $102.54 million.

• Nevro Corp's reported EPS for the quarter was a loss of $1.41​.

• The company reported a quarterly loss of $53.11 million.

• Nevro Corp shares had risen by 53.8% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 1.4% in the last three months.​

• In the last 30 days, two analysts negatively revised earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 13 "hold" and 1 "sell" or "strong sell."

• The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "hold"

Wall Street's median 12-month price target for Nevro Corp is $5.85

This summary was machine generated from LSEG data March 5 at 03:00 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)